NIA Study Confirms Protandim Nrf2 Synergizer Extends Life
August 02 2016 - 9:00AM
New Study from the National
Institute of Aging Interventions Testing Program (NIA ITP) Shows
Protandim Significantly Extends Lifespan in Male Mice
SALT LAKE CITY, Aug. 02, 2016 (GLOBE NEWSWIRE) --
A new study sponsored by the NIA ITP and published
in Aging Cell found what developers
and users of LifeVantage have held to be true for a very long
time.
As part of the NIA ITP federally-funded program
that examines treatments with the "potential to extend lifespan and
delay disease and dysfunction," and thereby extend lifespan,
researchers provided the supplement Protandim®, the
Nrf2 Synergizer® to male
mice in a rigorous and carefully controlled study. The result:
Protandim was proven to "significantly increase the lifespan of
male mice, with a 7 percent increase in median survival." The
findings on female mice were less dramatically conclusive, showing
an increase in lifespan of 3 percent.
Since the NIA ITP program's inception in 1999,
Protandim is the only nutritional supplement tested that has been
proven to increase the median survival in mice, thus delaying the
aging process.
Protandim was chosen for testing based on positive
indications on its ability to suppress tumor-promoting oxidative
stress, cell proliferation and inflammation, and the ability to
protect the heart from oxidative stress and fibrosis in studies
published prior to 2010. Some of the other recognized nutritional
substances tested included fish oil, curcumin, green tea and
resveratrol. None of these individual ingredients were shown to
increase the lifespan of mice.
"We are extremely excited about these results from
the NIA ITP study and are enthusiastic about the continued
advancement of the research and findings that demonstrate
Protandim's veracity and effectiveness in additional studies to
come," said LifeVantage President and Chief Executive Officer
Darren Jensen.
For more information about the Protandim results
in the NIA's study, readers can click here or
visit: http://onlinelibrary.wiley.com/doi/10.1111/acel.12496/abstract.
About LifeVantage
Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a
science based network marketing company dedicated to visionary
science that looks to transform health, wellness and anti-aging
internally and externally at the cellular level. The company is the
maker of the Protandim® line of
scientifically validated dietary supplement, the
TrueScience® Anti-Aging
Skin Care Regimen, Canine Health®, the
AXIO® energy
product line and the PhysIQ(TM) smart weight management system.
LifeVantage was founded in 2003 and is headquartered in Salt Lake
City, Utah.
www.lifevantage.com
Forward Looking
Statements
This document contains forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism,
satisfaction or disappointment with current prospects, as well as
words such as "believe," "hopes," "intends," "estimates,"
"expects," "projects," "plans," "anticipates," "look forward to"
and variations thereof, identify forward-looking statements, but
their absence does not mean that a statement is not
forward-looking. Examples of forward-looking statements include,
but are not limited to, statements we make regarding our future
growth and distributor success. Such forward-looking statements are
not guarantees of performance and the Company's actual results
could differ materially from those contained in such statements.
These forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that
may cause the Company's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks
and uncertainties include, among others, those discussed in greater
detail in the Company's Annual Report on Form 10-K and the
Company's Quarterly Report on Form 10-Q under the caption "Risk
Factors," and in other documents filed by the Company from time to
time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the
forward-looking statements contained in this document. All
forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of
this document, except as required by law.
Company Relations Contact:
John Genna (801) 432-9172
Vice President of Communications
& Corporate Partnerships
Investor Relations Contacts:
Cindy England (801) 432-9036
Director of Investor Relations
-Or-
Scott VanWinkle (617) 956-6736
Managing Director, ICR
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: LifeVantage Corporation via Globenewswire
HUG#2032445
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Sep 2023 to Sep 2024